FI20145806A - Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi - Google Patents

Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi

Info

Publication number
FI20145806A
FI20145806A FI20145806A FI20145806A FI20145806A FI 20145806 A FI20145806 A FI 20145806A FI 20145806 A FI20145806 A FI 20145806A FI 20145806 A FI20145806 A FI 20145806A FI 20145806 A FI20145806 A FI 20145806A
Authority
FI
Finland
Prior art keywords
alcohol
redness
preparations
prevention
treatment
Prior art date
Application number
FI20145806A
Other languages
English (en)
Swedish (sv)
Other versions
FI128082B (fi
Inventor
Semi Korpela
Kari Syrjänen
Mikko Salaspuro
Osmo Suovaniemi
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20145806A priority Critical patent/FI128082B/fi
Priority to CN201510126922.1A priority patent/CN105434415A/zh
Priority to KR1020177010320A priority patent/KR20170052688A/ko
Priority to PCT/FI2015/050612 priority patent/WO2016042205A1/en
Priority to PL15841584.4T priority patent/PL3193859T3/pl
Priority to FIEP15841584.4T priority patent/FI3193859T3/fi
Priority to EP15841584.4A priority patent/EP3193859B1/en
Priority to US15/511,126 priority patent/US20170252312A1/en
Priority to JP2017514700A priority patent/JP2017527595A/ja
Publication of FI20145806A publication Critical patent/FI20145806A/fi
Application granted granted Critical
Publication of FI128082B publication Critical patent/FI128082B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20145806A 2014-09-15 2014-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi FI128082B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20145806A FI128082B (fi) 2014-09-15 2014-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi
CN201510126922.1A CN105434415A (zh) 2014-09-15 2015-03-23 用于治疗和预防饮酒潮红和酒精-诱导的过敏性反应的制剂
PCT/FI2015/050612 WO2016042205A1 (en) 2014-09-15 2015-09-15 Preparations for treatment and prevention of alcohol flushing and alcohol-induced hypersensitivity reactions
PL15841584.4T PL3193859T3 (pl) 2014-09-15 2015-09-15 Preparaty do leczenia i zapobiegania czerwienieniu po alkoholu i reakcjom nadwrażliwości wywołanym alkoholem
KR1020177010320A KR20170052688A (ko) 2014-09-15 2015-09-15 알코올 홍조 및 알코올-유발성 과민 반응의 치료 및 예방을 위한 제제
FIEP15841584.4T FI3193859T3 (fi) 2014-09-15 2015-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi
EP15841584.4A EP3193859B1 (en) 2014-09-15 2015-09-15 Preparations for treatment and prevention of alcohol flushing and alcohol-induced hypersensitivity reactions
US15/511,126 US20170252312A1 (en) 2014-09-15 2015-09-15 Preparations for treatment and prevention of alcohol flushing and alcohol-induced hypersensitivity reactions
JP2017514700A JP2017527595A (ja) 2014-09-15 2015-09-15 アルコールフラッシング反応およびアルコール誘発性過敏反応の治療および予防用製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20145806A FI128082B (fi) 2014-09-15 2014-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi

Publications (2)

Publication Number Publication Date
FI20145806A true FI20145806A (fi) 2016-03-16
FI128082B FI128082B (fi) 2019-09-13

Family

ID=55532597

Family Applications (2)

Application Number Title Priority Date Filing Date
FI20145806A FI128082B (fi) 2014-09-15 2014-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi
FIEP15841584.4T FI3193859T3 (fi) 2014-09-15 2015-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FIEP15841584.4T FI3193859T3 (fi) 2014-09-15 2015-09-15 Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi

Country Status (8)

Country Link
US (1) US20170252312A1 (fi)
EP (1) EP3193859B1 (fi)
JP (1) JP2017527595A (fi)
KR (1) KR20170052688A (fi)
CN (1) CN105434415A (fi)
FI (2) FI128082B (fi)
PL (1) PL3193859T3 (fi)
WO (1) WO2016042205A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114144493A (zh) * 2019-05-23 2022-03-04 Ekyj Ii 咨询有限责任公司 治疗和减轻酒精诱导的皮肤潮红的组合物和方法
CN112972395B (zh) * 2019-12-02 2022-12-13 湖北舒邦药业有限公司 胶囊制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012027603A2 (en) * 2010-08-26 2012-03-01 Clarity Products, Limited Liability Company Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
EP2589381B1 (en) * 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions for improving or preserving lung function in a patient with a pulmonary disorder
FI129157B (fi) * 2012-05-28 2021-08-13 Biohit Oyj Koostumus käytettäväksi vakavien päänsärkyjen esiintymistiheyden pienentämiseksi tai niiden vähentämiseksi
CN102727474A (zh) * 2012-06-29 2012-10-17 天津科技大学 L-半胱氨酸在制备解酒药物、保护肝脏及肾脏药物中的应用
EP2869717B8 (en) * 2012-07-09 2018-07-25 NoGlo, Inc. Prevention of alcohol reaction with dietary supplements
WO2014143192A1 (en) * 2013-03-13 2014-09-18 Noglo Llc Reduction or prevention of alcohol reaction with dietary supplements
US20140256760A1 (en) * 2012-07-09 2014-09-11 Noglo Llc Reduction or prevention of alcohol reaction with dietary supplements
US20150202181A1 (en) * 2013-01-23 2015-07-23 Paolo B DePetrillo Method of and compounds for the reduction of alcoholic hangover

Also Published As

Publication number Publication date
WO2016042205A1 (en) 2016-03-24
KR20170052688A (ko) 2017-05-12
FI128082B (fi) 2019-09-13
JP2017527595A (ja) 2017-09-21
FI3193859T3 (fi) 2023-08-07
PL3193859T3 (pl) 2023-11-20
EP3193859A4 (en) 2018-04-18
US20170252312A1 (en) 2017-09-07
EP3193859A1 (en) 2017-07-26
EP3193859B1 (en) 2023-07-05
CN105434415A (zh) 2016-03-30

Similar Documents

Publication Publication Date Title
GB2549545B (en) Forensic analysis of computing activity
HK1249103B (zh) 多環氨甲醯基吡啶酮化合物及其藥物用途
EP3429635A4 (en) ANTI-CRISPR COMPOUNDS AND METHODS OF USE
EP3504213A4 (en) AMINO-PYRROLOPYRIMIDINONE COMPOUNDS AND METHODS OF USE
EP3377070A4 (en) COMPOUNDS AND METHOD FOR THEIR USE
HK1253049A1 (zh) 糖基相互作用化合物及其使用方法
PT3548033T (pt) Compostos e respectivos métodos de utilização
EP3104706A4 (en) Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
BR112016027041A2 (pt) Combinações farmacêuticas para tratamento do câncer
EP3218005A4 (en) Glycan-interacting compounds and methods of use
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
HK1258276A1 (zh) 用於治療hiv的化合物和組合
EP3541847A4 (en) COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
HK1251225A1 (zh) 新型苯並咪唑化合物及其製藥用途
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
FI20145305A (fi) Proteiinituotteet ja menetelmät niiden valmistamiseksi
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
HK1249425A1 (zh) 間-碘苄基胍及其前體的製劑
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
FI20145806A (fi) Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi
PT3340975T (pt) Formulação para o tratamento de acne
IL257689A (en) Pharmacological preparations and methods for the treatment of diseases associated with hypoxia
ZA201608823B (en) Processes for the preparation of azd5363 and novel intermediate used therein
AP2016009662A0 (en) Combination of taurine and racemethionine for treatment of liver diseases

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 128082

Country of ref document: FI

Kind code of ref document: B